Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $24,421 - $27,689
509 Added 3.58%
14,717 $798,000
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $2,424 - $2,892
50 Added 0.35%
14,208 $729,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $47,701 - $53,337
-824 Reduced 5.5%
14,158 $821,000
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $16,164 - $18,334
-246 Reduced 1.62%
14,982 $1.04 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $139,973 - $165,747
-2,044 Reduced 11.83%
15,228 $1.1 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $42 - $24,896
-324 Reduced 1.84%
17,272 $1.23 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $10,747 - $11,837
-148 Reduced 0.83%
17,596 $1.36 Million
Q1 2022

May 18, 2022

BUY
$61.48 - $73.72 $1.09 Million - $1.31 Million
17,744 New
17,744 $1.3 Million
Q4 2021

Feb 03, 2022

SELL
$53.63 - $62.52 $1.01 Million - $1.17 Million
-18,742 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $415,905 - $487,179
-7,029 Reduced 27.27%
18,742 $1.11 Million
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $12,072 - $13,146
-195 Reduced 0.75%
25,771 $1.72 Million
Q1 2021

Apr 29, 2021

SELL
$59.34 - $66.74 $53,465 - $60,132
-901 Reduced 3.35%
25,966 $1.64 Million
Q4 2020

Jan 22, 2021

SELL
$57.74 - $65.43 $2,656 - $3,009
-46 Reduced 0.17%
26,867 $1.67 Million
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $3,563 - $4,165
-65 Reduced 0.24%
26,913 $1.58 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $276,404 - $401,680
5,957 Added 28.34%
26,978 $1.5 Million
Q4 2019

Feb 10, 2020

SELL
$49.21 - $64.19 $370,551 - $483,350
-7,530 Reduced 26.37%
21,021 $1.35 Million
Q2 2019

Jul 23, 2019

SELL
$44.62 - $49.34 $10,039 - $11,101
-225 Reduced 0.78%
28,551 $1.3 Million
Q1 2019

May 07, 2019

SELL
$45.12 - $53.8 $72,101 - $85,972
-1,598 Reduced 5.26%
28,776 $1.37 Million
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $13,409 - $17,388
-275 Reduced 0.9%
30,374 $1.58 Million
Q3 2018

Nov 19, 2018

SELL
$55.19 - $62.25 $23,731 - $26,767
-430 Reduced 1.38%
30,649 $1.9 Million
Q2 2018

Jul 26, 2018

SELL
$50.53 - $62.98 $5,558 - $6,927
-110 Reduced 0.35%
31,079 $1.72 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $107,017 - $123,198
-1,786 Reduced 5.42%
31,189 $1.97 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $115,384 - $125,798
-1,925 Reduced 5.52%
32,975 $2.02 Million
Q3 2017

Nov 09, 2017

SELL
$55.23 - $63.74 $8,284 - $9,561
-150 Reduced 0.43%
34,900 $2.23 Million
Q2 2017

Aug 11, 2017

BUY
N/A
35,050
35,050 $1.95 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.